These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 24861410

  • 1. Microbiocidal effects of various taurolidine containing catheter lock solutions.
    Olthof ED, Nijland R, Gülich AF, Wanten GJ.
    Clin Nutr; 2015 Apr; 34(2):309-14. PubMed ID: 24861410
    [Abstract] [Full Text] [Related]

  • 2. Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.
    Olthof ED, Rentenaar RJ, Rijs AJ, Wanten GJ.
    Clin Nutr; 2013 Aug; 32(4):538-42. PubMed ID: 23267744
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
    Dümichen MJ, Seeger K, Lode HN, Kühl JS, Ebell W, Degenhardt P, Singer M, Geffers C, Querfeld U.
    J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
    [Abstract] [Full Text] [Related]

  • 4. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK, Mermel LA, LaPlante KL.
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [Abstract] [Full Text] [Related]

  • 5. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S, Szczepanek K, Hermanowicz A, Galas A.
    JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
    [Abstract] [Full Text] [Related]

  • 6. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
    Chu HP, Brind J, Tomar R, Hill S.
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
    [Abstract] [Full Text] [Related]

  • 7. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
    Tribler S, Brandt CF, Petersen AH, Petersen JH, Fuglsang KA, Staun M, Broebech P, Moser CE, Jeppesen PB.
    Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
    [Abstract] [Full Text] [Related]

  • 8. Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis.
    Nguyen T, Camins BC, Butler DA.
    Am J Ther; 2017 Sep; 31(4):e398-e409. PubMed ID: 38710029
    [Abstract] [Full Text] [Related]

  • 9. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
    Olthof ED, Versleijen MW, Huisman-de Waal G, Feuth T, Kievit W, Wanten GJ.
    PLoS One; 2014 Sep; 9(11):e111216. PubMed ID: 25379781
    [Abstract] [Full Text] [Related]

  • 10. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R, Adelt M, Chrul S.
    Am J Ther; 2016 Sep; 23(2):e363-8. PubMed ID: 23665885
    [Abstract] [Full Text] [Related]

  • 11. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
    Lambe C, Poisson C, Talbotec C, Goulet O.
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1017-1025. PubMed ID: 29385236
    [Abstract] [Full Text] [Related]

  • 12. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG, van Agteren M.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition.
    Daoud DC, Wanten G, Joly F.
    Nutrients; 2020 Feb 10; 12(2):. PubMed ID: 32050544
    [Abstract] [Full Text] [Related]

  • 14. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial.
    Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ.
    Clin Nutr; 2010 Aug 10; 29(4):464-8. PubMed ID: 20061070
    [Abstract] [Full Text] [Related]

  • 15. Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patients.
    Touré A, Lauverjat M, Peraldi C, Boncompain-Gerard M, Gelas P, Barnoud D, Chambrier C.
    Clin Nutr; 2012 Aug 10; 31(4):567-70. PubMed ID: 22285029
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y, Roosenboom B, Causevic E, Kievit W, Groenewoud H, Wanten GJA.
    Clin Nutr; 2019 Oct 10; 38(5):2210-2218. PubMed ID: 30292482
    [Abstract] [Full Text] [Related]

  • 17. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C, Nicolae S, Royo-Cebrecos C, Aguilar-Guisado M, Montero I, Martín-Gandul C, Perayre M, Berbel D, Encuentra M, Arnan M, Cisneros-Herreros JM, Carratalà J.
    Trials; 2018 May 02; 19(1):264. PubMed ID: 29720244
    [Abstract] [Full Text] [Related]

  • 18. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
    Arnoriaga Rodríguez M, Pérez de Ciriza Cordeu M, Camblor Álvarez M, Bretón Lesmes I, Motilla de la Cámara M, Velasco Gimeno C, Arhip L, García Peris P, Cuerda Compés C.
    Nutr Hosp; 2018 Jun 28; 35(4):761-766. PubMed ID: 30070861
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
    Al-Amin AH, Sarveswaran J, Wood JM, Burke DA, Donnellan CF.
    J Vasc Access; 2013 Jun 28; 14(4):379-82. PubMed ID: 23817948
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.
    Piątkowska E, Paleczny J, Dydak K, Letachowicz K.
    PLoS One; 2021 Jun 28; 16(10):e0258148. PubMed ID: 34618850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.